Signalling: A new trick for an old lipid
Cholesterol is a lipid molecule that is a vital component of all animal cell membranes. It provides structural integrity, which is needed for the membrane to be an effective barrier, and is also required for the production of hormones and vitamin D. These roles mean the production and transport of cholesterol in cells is strictly regulated. This, combined with its poor solubility, has hindered efforts to study its specific molecular roles. Despite this, cholesterol has long been connected to the Hedgehog signalling pathway, which helps to regulate how tissues form in animals and is mutated in several types of cancer.
Now, in eLife, Rajat Rohatgi from Stanford University, Christian Siebold from the University of Oxford and colleagues – including Giovanni Luchetti and Ria Sircar as joint first authors – report a new role for cholesterol in activating the Hedgehog pathway through the receptor protein Smoothened (Luchetti et al., 2016). Similar results have also been recently reported by Adrian Salic and colleagues (Huang et al., 2016).
There are three main components in the Hedgehog pathway that allow cells to send and receive signals: the signalling protein Hedgehog, a transmembrane protein called Patched, and a transmembrane receptor protein called Smoothened. In the absence of Hedgehog, Patched inhibits Smoothened. However, when Hedgehog binds to Patched, this inhibition is blocked and Smoothened is able to activate other Hedgehog pathway components inside the cell. It is thought that Patched and Smoothened communicate using a small molecule rather than by direct contact (Taipale et al., 2002), but it is not clear exactly how this works.
Smoothened possesses two sites at which small molecules are able to bind: one is in its transmembrane domain region and the other is in its cysteine-rich domain on the external surface of the cell. A similar cysteine-rich domain is found in several other proteins, where it is known to be able to bind to lipids (Bazan et al., 2009). Earlier this year, Rohatgi, Siebold and colleagues presented the first complete crystal structure of the transmembrane domain region and cysteine-rich domain of Smoothened (Byrne et al., 2016). Unexpectedly, they found a cholesterol molecule occupied a hydrophobic (water-fearing) pocket in the cysteine-rich domain. Since disrupting cholesterol production in humans and mice affects Smoothened activity (Blassberg et al., 2016; Cooper et al., 2003), this raised the possibility that cholesterol might directly bind to and regulate Smoothened.
Cholesterol is a challenging molecule to work with because it is hydrophobic and can randomly integrate into membranes and modify the activities of many proteins. To overcome this problem both Luchetti et al. and Huang et al. used a chemical called methyl-β-cyclodextrin to deliver cholesterol to cells and show that it directly activates Smoothened through its cysteine-rich domain.
There are many common findings between the two studies. Firstly, both teams demonstrate that cholesterol stimulates Hedgehog signalling via Smoothened with a high degree of specificity. For example, cholestenol and other molecules that are similar to cholesterol were unable to do the same. Both teams were able to rule out the transmembrane domain region as the site of cholesterol binding by showing that cholesterol could activate Smoothened even in the presence of mutations that block the binding of small molecules to this region. By contrast, mutating or completely removing the cysteine-rich domain of Smoothened blocked both the cholesterol and Hedgehog responses. Furthermore, the presence of cholesterol and Hedgehog protein together led to higher levels of Hedgehog signalling activity than the presence of just Hedgehog protein, indicating a possible role for Patched in the regulation of Smoothened by cholesterol (Figure 1).
How does cholesterol binding outside the cell translate to signalling within the cell? Luchetti et al. predict, based on previous structures (Byrne et al., 2016), that cholesterol binding to the cysteine-rich domain of Smoothened induces a clockwise rotation with respect to the transmembrane domain region. This change in shape could be sufficient to promote signalling inside the cell.
Together the findings of Luchetti et al. and Huang et al. strongly support a role for cholesterol in activating Smoothened in cells. However, it is worth noting that recent findings from other research groups favour an inhibitory role for sterol molecules instead (Roberts et al., 2016; Sever et al., 2016). Therefore, several critical questions remain. Does cholesterol binding itself alter Smoothened activity, or is cholesterol merely a cofactor that is needed for Smoothened to be activated by another molecule? Does Hedgehog protein affect cholesterol levels and is this mediated through the activity of Patched (Figure 1)? Since most cholesterol is trapped within the cell membrane, it will also be important to understand how cholesterol is able to access the cysteine-rich domain of Smoothened.
Nonetheless, this work reveals a new signalling role for cholesterol in controlling the Smoothened receptor and reiterates the possibility that Hedgehog signalling may have evolved from an ancient lipid-sensing pathway (Hausmann et al., 2009).
References
-
Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndromeHuman Molecular Genetics 25:693–705.https://doi.org/10.1093/hmg/ddv507
Article and author information
Author details
Publication history
Copyright
© 2016, Sharpe
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,336
- views
-
- 176
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
Malaria parasites have evolved unusual metabolic adaptations that specialize them for growth within heme-rich human erythrocytes. During blood-stage infection, Plasmodium falciparum parasites internalize and digest abundant host hemoglobin within the digestive vacuole. This massive catabolic process generates copious free heme, most of which is biomineralized into inert hemozoin. Parasites also express a divergent heme oxygenase (HO)-like protein (PfHO) that lacks key active-site residues and has lost canonical HO activity. The cellular role of this unusual protein that underpins its retention by parasites has been unknown. To unravel PfHO function, we first determined a 2.8 Å-resolution X-ray structure that revealed a highly α-helical fold indicative of distant HO homology. Localization studies unveiled PfHO targeting to the apicoplast organelle, where it is imported and undergoes N-terminal processing but retains most of the electropositive transit peptide. We observed that conditional knockdown of PfHO was lethal to parasites, which died from defective apicoplast biogenesis and impaired isoprenoid-precursor synthesis. Complementation and molecular-interaction studies revealed an essential role for the electropositive N-terminus of PfHO, which selectively associates with the apicoplast genome and enzymes involved in nucleic acid metabolism and gene expression. PfHO knockdown resulted in a specific deficiency in levels of apicoplast-encoded RNA but not DNA. These studies reveal an essential function for PfHO in apicoplast maintenance and suggest that Plasmodium repurposed the conserved HO scaffold from its canonical heme-degrading function in the ancestral chloroplast to fulfill a critical adaptive role in organelle gene expression.
-
- Biochemistry and Chemical Biology
- Cell Biology
Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.